Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chloroxylenol + hydrocortisone + pramoxine hydrochloride 1mg/10mg/10mg drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate + pramoxine hydrochloride 1%wv/1%wv lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate + pramoxine hydrochloride 1%ww/1%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Chloroxylenol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Clioquinol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone 1% + Pramocaine 1% foam enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |